IACP News Roundup - October 27, 2017

To keep you informed on all of IACP  member-driven initiatives  and latest legislative & regulatory updates, IACP has debuted a weekly  News Roundup ! Check out this week's report below, and email us at  [email protected]   with questions.


Save the Date for IACP's Educational Conference!

IACP President Baylor Rice and President- 
Elect Erik Tosh
WATCH   IACP President Baylor Rice, RPh, FIACP and President-Elect Erik Tosh, BS, RPh, FIACP, FACA, as they urge you to Save the Date for I ACP's Educational Conference & Inaugural President's Gala, January 24-27, 2018 in Ft. Lauderdale, Fla! #EduCon2018! More information and register here!

Please join us and your colleagues at the Sonesta Fort Lauderdale Beach for a jam-packed agenda filled with exciting educational sessions and connect with your colleagues during the President's Gala, receptions, and time with IACP exhibitors! The IACP exhibit hall is already sold out and the room block is filling up quickly, so please register now! We look forward to seeing you in Ft. Lauderdale!

ABOUT

EVP Tracker
  • IACP wants you to have access to the EVP, the staff, as well as the Board of Directors. Stay up-to-date on where IACP's Executive Vice President Cynthia Blankenship, Esq. is traveling, and set-up meetings or come by and say hi! Keep up-to-date on Cynthia's whereabouts with the EVP Tracker and let her know if you would like to host a townhall or meeting at your pharmacy! 
Next on Cynthia's travel plans:


* IACP EVP Cynthia Blankenship has been appointed as the United States Pharmacopeia (USP) delegate representing IACP. The delegate is invited to attend the USP five-year meeting in 2020 and the twice per year Compounding Expert Committee (CEC) meeting as an observer. 

Member Initiatives
  • IACP Initiatives - A Progress Report Card! Keep tuning in to IACP's  Executive Vice President (EVP) Cynthia Blankenship's Member Initiatives  t o see where we're making progress and what we're checking off the list! You asked IACP for several key changes - and we're making them! IACP is in the midst of reviewing & revitalizing ALL of our current programs. We want to ensure we're completely in tune with our membership, providing you with what you need. Do you have suggestions or questions? Please email  [email protected] .   
IACP Board of Directors Nominations Now Closed
  • The nominations period for the IACP Board of Directors 2018-2020 election cycle has closed. Thank you for all the suggested candidates we received! The number of suggested candidates was tremendous and we are so grateful to have members as engaged and excited about the organization as you. IACP is a success because of YOU! Your work is what helps make us the great organization that we are. Read next steps and check out the suggested nominees here!
IACP Affiliate Member News
  • Call for Representatives for American Pharmacists Association's (APhA) 2018 Remington Honor Medalist Screening Committee! IACP has been asked to participate in the selection process for APhA's 2018 Remington Honor Medal! IACP will submit two representative nominations to serve on the Remington Medal's Screening Committee. Please email your interest in serving along with a brief biographical sketch no later than Wednesday, November 1, 2017. Please note: If possible, participants should not have served on prior Remington Honor Medal Screening Committees more than twice in the past. 
One-on-One with IACP President Baylor Rice

Join  IACP President Baylor Rice, RPh, FIACP , as he brings you a series of articles, answering your questions on all of the exciting activities IACP has underway! 

Today, Baylor answers member questions on IACP's fundraising efforts. What's the best way to support IACP and all of the member initiatives we have in progress? What funds and efforts need your contributions the most? What are the missions/objectives for each of IACP's fundraising opportunities? How is your money being used?

Here  is an overview we hope will provide clarity on our fundraising efforts! Thank you to all those who have donated to the IACP mission! Please join us in donating to preserve patient access to life-saving compounded medications!


NEWSROOM

Member Alerts
Member Newsletter
Media

IACP Featured in Bloomberg Law Article: "Is FDA Going Too Far in Enforcing Drug Compounding Law?"

The International Academy of Compounding Pharmacists (IACP) was featured heavily in a Bloomberg Law article published yesterday, "Is FDA Going Too Far in Enforcing Drug Compounding Law?" written by Bronwyn Mixter.

(Reproduced with permission from Pharmaceutical Law & Industry Report, 15 PLIR (OCT. 25, 2017). Copyright 2017 by The Bureau of National Affairs, Inc. (800-372-1033) < http://www.bna.com>)

Article Excerpt: "Addressing Food & Drug Administration (FDA) Guidance Documents and concerns that FDA has issued no rules for compounding but only guidance documents, which aren't legally enforceable, IACP Executive Vice President Cynthia Blankenship says, 'Mass confusion has resulted from the usage of guidance documents, and the FDA is definitely circumventing the Administrative Procedure Act (APA) in our opinion,' The APA governs how federal agencies propose and establish regulations. IACP wants Congress to pass a bill (H.R. 2871) they say will fix these issues."

Please click here to read more.

MEMBERSHIP

Membership Survey
  • Have You Completed IACP's Membership Survey? IACP is seeking your input on our programs, services, products, and demographics about your practice. IACP values our members and your feedback! We will use YOUR feedback to shape not only the direction of IACP, but also the resources IACP provides, our communications to you, and our events!  IACP Members: Click here to complete the survey. IACP will be keeping in touch with you and regularly engaging your opinions. And, most importantly, communicating back to you the changes we're making based on your opinions.
Membership Drive
  • IACP Extends Membership Drive! Sign Up your Staff for 25% off NEW IACP Memberships. Share this with Your Colleagues! Due to the incredible number of members to join IACP during the membership drive, IACP has extended our membership drive! Use code CCH25, and click here to save! 
ADVOCACY

Federal Advocacy
  • The  Food & Drug Administration (FDA) this week announced a  Pharmacy Compounding Advisory Committee (PCAC) meeting to occur on November 20-21, 2017 during the week of the Thanksgiving holiday.  PLEASE NOTE: The PCAC meeting will be open to the public, and you are encouraged to submit comments and attend the meeting. Please  click here  for more information including a statement from  IACP's Executive Vice President Cynthia Blankenship .  
  • Your Efforts are Making a Difference! We Now Have 40 HR 2871 Cosponsors! Has Your Representative Signed On? Please send a direct communication to your Member of Congress. HR 2871 will help clarify the Drug Quality & Security Act (DQSA) in a way that will better align the statute with congressional intent and most importantly, better balance public safety and patient access. Act, Today!
State Advocacy
  • NOW AVAILABLE FROM IACP! State-by-State Analysis of Office-Use Compounding Regulations! Your Government Affairs team just released a State-by-State Analysis of Office-Use Regulations! We researched State regulations, State notices, State activity, and called State Boards of Pharmacy when regulations conflicted with actions to determine each State's office-use actions. In the instance where a State had recently changed its office-use practices, we called to determine why, and the response was noted when FDA had communicated that State law was pre-empted with Federal law.
You will find two documents - (1) the State-by-State analysis and (2) a complete supplemental document where all State regulations and actions are housed. The State-by-State analysis is a quick reference guide that demonstrates State regulations and current thinking on office-use and all supporting documents to this research can be found in the supplemental document. The DQSA Coalition intends to use this document to see whether model office-use State laws exist, to educate and assist States that are attempting to change office-use practices on the intent of Congress, and to focus on specific states for the State Board of Pharmacy/Board of Medicine Coalition Letter that is coming soon!  
  • IACP provides our members with a weekly state tracking report - including legislative and regulatory updates! Check out this week's Compounders Stateside report here - you will need to log-in to view this members-only report.  
  • USP General Chapter <800> State Adoption Status Chart. NASPA has developed a chart providing each state's current adoption status of USP's General Chapter <800>. Thank you, IACP Affiliate NASPA, for developing this invaluable tool!
Grassroots
  • Grassroots Advocacy - Tell Your Patients and Providers to sign up for the Partnership for Personalized Prescriptions P3 Patient Advocacy Website! Patient Advocacy efforts make a real difference. That's why we need our IACP members' help to encourage more people to Join P3 and to Share their Stories! So many of our own IACP members have joined the P3 effort. Share this resource with everyone in your communities - your patients, your providers, your staff, your friends and family.
  • Your Patients and Providers are Asking their Representatives to Support HR 2871 with 524 messages sent to the Hill! Encourage your patients and providers to visit P3's Patient Advocacy Website. Advocates can instantly send a direct message to their Congressional Representatives, asking them to cosponsor the bipartisan legislation, HR 2871. Visit P3's Patient Advocacy Website. It's easy to use and will only take a few minutes to send an important HR 2871 message to Congress.
  • IACP MEMBERS: We NEED your patient stories to feature on the P3 website - how have compounded medications helped your community? Please email Dagmar Anderson Climo, VP of IACP Communications at [email protected].